Skip to content

Novotech Wins Prestigious Brandon Hall Gold Award for CRA Monitoring Simulation Program under the category of Best Competencies and Skill Development

By API User

BOSTON–BUSINESS WIRE– Novotech, a leading full-service clinical Contract Research Organization (CRO), is proud to announce that its Clinical Research Associate (CRA) Monitoring Simulation Program has been recognized with the Brandon Hall Gold Award in the category of Best Competencies and Skill Development. This program is now available to all relevant CRAs in Novotech. This prestigious … Continued

Merck Unveils New MAVENCLAD® Four-Year Data Highlighting Benefits of Early Treatment and Sustained Efficacy Across Multiple Measures of Disease Activity

By API User

Phase IV studies demonstrate the consistent safety and high efficacy of MAVENCLAD on NEDA-3, MRI and cognition outcomes over four years New data on blood and CSF biomarkers show the impact of MAVENCLAD to promote immune cell reconstitution, while clinical data confirmed 93.7% of patients free from PIRA MAVENCLAD has now treated more than 100,000 … Continued

ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors

By API User

ITM gains exclusive global development and commercialization rights to Debiopharm’s first-in-class, peptide-based theranostic pair which combines therapeutic compound, Debio 0228 ([177Lu]Lu-DPI-4452) and diagnostic imaging agent, Debio 0328 ([68Ga]Ga-DPI-4452) to target Carbonic Anhydrase IX (CA IX) Debiopharm to receive upfront, development and regulatory milestone payments of approximately €300 million, as well as commercial milestones and low … Continued

Australians with diabetes missing out on crucial medications

By API User

More Australians with type 2 diabetes should gain access to potentially lifesaving medications, a new analysis has found.  UNSW medical researchers say more Australians with type 2 diabetes need to be offered add-on medications that would better protect them from heart and kidney disease – which are among the major causes of death for people with … Continued

Vale Bill Whittaker

By API User

It is with deep sadness that Health Equity Matters and the National Association of People with HIV Australia (NAPWHA) note the passing of Bill Whittaker, a visionary leader and tireless advocate in Australia’s community-led response to HIV.   Bill Whittaker’s journey with HIV began in the earliest days of the epidemic, before effective treatments were … Continued

NeuRA researchers identify new functional brain imaging method

By API User

Researchers from NeuRA (Neuroscience Research Australia) have developed a new method for functional brain imaging. Scientists are hopeful the new imaging method will assist in studies of normal brain function and early detection of neurodegenerative conditions. By combining high-resolution imaging with real-time data on tissue function, this technique represents a significant leap forward in the … Continued

Neuraptive Therapeutics Receives FDA Breakthrough Therapy Designation for NTX-001 and Provides Update on the Advancements of NTX-001 for the Treatment of Peripheral Nerve Injury Requiring Repair

By API User

– Breakthrough Therapy designation for NTX-001 granted by FDA – Preparation is underway for the Phase 3 program to begin in early 2025 CHESTERBROOK, Pa.–BUSINESS WIRE– Neuraptive Therapeutics, Inc. today announced that NTX-001 has been granted Breakthrough Therapy Designation, thus providing the potential for accelerated development for patients with peripheral nerve injury requiring repair. This … Continued